UK advisory body releases report on impact of DNA patents on diagnostics innovation
This article was originally published in Clinica
Executive Summary
A report by the UK Human Genetics Commission on the impact of DNA patents on diagnostics innovation highlights the tension between rising regulatory hurdles – in the form of demands for greater evidence of clinical utility – and the lack of incentive to make the necessary investment in clinical research.